Target Name: OR51I2
NCBI ID: G390064
Review Report on OR51I2 Target / Biomarker Content of Review Report on OR51I2 Target / Biomarker
OR51I2
Other Name(s): Odorant receptor HOR5'beta12 | O51I2_HUMAN | HOR5'Beta12 | Olfactory receptor 51I2 | Olfactory receptor family 51 subfamily I member 2 | olfactory receptor family 51 subfamily I member 2 | Olfactory r

OR51I2 Receptor: A Potential Drug Target

Odorant receptor HOR5'beta12 (OR51I2) is a G protein-coupled receptor located on the surface of various cell types in the body. It is one of the five known subtypes of the OR51 family of G protein-coupled receptors, which are involved in various physiological processes in the body, including sensory perception and neurotransmission. HOR5'beta12 is expressed in the central nervous system (CNS) and is involved in the sense of smell, as well as in the regulation of pain, anxiety, and inflammation.

Due to its involvement in multiple physiological processes, OR51I2 has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. In this article, we will discuss the OR51I2 receptor, its function in the body, potential drug targets, and its current status as a drug target.

OR51I2 Receptor

OR51I2 is a type of G protein-coupled receptor that is characterized by its long, N-terminal extracellular domain and a single transmembrane segment. It has four transmembrane domains, including an intracellular loop, a transmembrane segment, and an extracellular loop. The intracellular loop is responsible for the formation of the G protein-coupled receptor complex, which is a protein-protein interaction that involves the exchange of genetic information between the extracellular domain of the receptor and intracellular signaling molecules.

OR51I2 is involved in the sense of smell, which is the ability to detect and identify odors in the environment. It is sensitive to a wide range of odors, including scents such as soap, spices, and flowers. OR51I2 is also involved in the regulation of pain, anxiety, and inflammation. For example, studies have shown that OR51I2 is involved in the modulation of pain perception and that it may play a role in the development of anxiety disorders.

Potential Drug Targets

OR51I2 has been identified as a potential drug target due to its involvement in multiple physiological processes. Some of the potential drug targets for OR51I2 include:

1. Pain Modulation: OR51I2 is involved in the modulation of pain perception and has been shown to play a role in the development of chronic pain disorders. Drugs that can modulate OR51I2 activity, such as nonsteroidal anti-inflammatory drugs (NSAIDs), may be effective in reducing pain.
2. Anxiety and Depression: OR51I2 is involved in the regulation of anxiety and depression, and has been shown to play a role in the development of these disorders. Drugs that can modulate OR51I2 activity, such as selective serotonin reuptake inhibitors (SSRIs), may be effective in treating anxiety and depression.
3. Inflammation: OR51I2 is involved in the regulation of inflammation and has been shown to play a role in the development of inflammatory disorders. Drugs that can modulate OR51I2 activity, such as corticosteroids, may be effective in treating inflammatory disorders.

Current Status as a Drug Target

OR51I2 is currently being targeted as a drug target for a variety of diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Some of the most promising compounds that have been shown to modulate OR51I2 activity include:

1. Small Molecules: A number of small molecules have been shown to modulate OR51I2 activity, including compounds such as ammonium, imidazole, and pyridostigmine. These compounds act on the intracellular loop of the OR51I2 receptor to modulate its activity.
2. Cholinesterase Inhibitors: Cholinesterase inhibitors, which are drugs that inhibit the activity of enzymes that break down neurotransmitters, have been shown to be effective in modulating OR51I2 activity. These drugs work by protecting neurotransmitters from degradation and increasing their levels in the brain.
3. Blockers: Blockers, which are drugs that interfere with the action of other drugs, have also been shown to be effective in modulating OR51I2 activity. These drugs work by binding to the OR51I2 receptor and blocking its activity.

Conclusion

OR51I2 is a G protein-coupled receptor that is involved in the sense of smell and the regulation of pain, anxiety, and inflammation. It has been identified as a potential drug target due to its involvement in multiple physiological processes and its potential to modulate the activity of other drugs. While further research is needed to fully understand the function of OR51I2 as a drug target, its potential as a therapeutic agent in the treatment of various psychiatric and neurological disorders is an exciting area of research.

Protein Name: Olfactory Receptor Family 51 Subfamily I Member 2

Functions: Odorant receptor

The "OR51I2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR51I2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2